Publications by authors named "Manon Cox"

Claim this Profile
E
Expansion and Storage of Insect Cells and Virus Stocks.
Manon M J Cox

Methods Mol Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meet the fellows: Everything about ISV.
Denise Doolan, Shan Lu, Ted Ross, Manon Cox

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2021 ISV Annual Virtual Congress.
Manon Cox

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production.
Manon M J Cox

Vaccines (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycobiotechnology of the Insect Cell-Baculovirus Expression System Technology.
Laura A Palomares, Indresh K Srivastava, Octavio T Ramírez, Manon M J Cox

Adv Biochem Eng Biotechnol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial.
Lisa M Dunkle, Ruvim Izikson, Peter A Patriarca, Karen L Goldenthal, Manon Cox

Pediatrics· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine Technology VI: Innovative and integrated approaches in vaccine development.
Laura A Palomares, Tarit K Mukhopadhyay, Yvonne Genzel, Linda H L Lua, Manon M J Cox

Vaccine· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.
Lisa M Dunkle, Ruvim Izikson, Peter A Patriarca, Karen L Goldenthal, Derek Muse, Manon M J Cox

J Infect Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans.
Daniel Stadlbauer, Arvind Rajabhathor, Fatima Amanat, Daniel Kaplan, Abusaleh Masud, Manon M Cox

mSphere· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern technology: The preferred biosecurity strategy?
Manon Cox

Vaccine· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine.
Yoshikazu Honda-Okubo, Harinda Rajapaksha, Dimitar Sajkov, David Gordon, Manon M J Cox

Hum Vaccin Immunother· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.
Lisa M Dunkle, Ruvim Izikson, Peter Patriarca, Karen L Goldenthal, Derek Muse, Manon M J Cox

N Engl J Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete study demonstrating the absence of rhabdovirus in a distinct Sf9 cell line.
Yoshifumi Hashimoto, Daniel Macri, Indresh Srivastava, Clifton McPherson, Rachael Felberbaum, Manon Cox

PLoS One· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.
Madhusudan Rajendran, Raffael Nachbagauer, Megan E Ermler, Paul Bunduc, Fatima Amanat, Manon Cox

mBio· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant.
Clifton McPherson, Richard Chubet, Kathy Holtz, Yoshikazu Honda-Okubo, Dale Barnard, Manon Cox

Methods Mol Biol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
My passion is to drive innovation in vaccine development.
Manon Cox

Hum Vaccin Immunother· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.
Raffael Nachbagauer, Angela Choi, Ruvim Izikson, Manon M Cox, Peter Palese

mBio· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells.
Jamal Meghrous, Nikolai Khramtsov, Barry C Buckland, Manon M J Cox, Laura A Palomares

Biotechnol Bioeng· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate.
David G Rhodes, Kathy Holtz, Pam Robinson, Keyang Wang, Clifton E McPherson, Manon M J Cox

Vaccine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison of the safety of Flublok(®) versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥ 50 years of age.
Ruvim Izikson, David J Leffell, S Allan Bock, Peter A Patriarca, Penny Post, Manon M J Cox

Vaccine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine Technology V: The art of taking vaccines to disease prevention.
Laura A Palomares, Barry C Buckland, Yvonne Genzel, Manon M J Cox

Vaccine· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Titer on chip: new analytical tool for influenza vaccine potency determination.
Laura R Kuck, Michelle Sorensen, Erin Matthews, Indresh Srivastava, Manon M J Cox

PLoS One· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults.
Manon M J Cox, Ruvim Izikson, Penny Post, Lisa Dunkle

Ther Adv Vaccines· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss.
Kathleen M Holtz, Pamela S Robinson, Erin E Matthews, Yoshifumi Hashimoto, Clifton E McPherson, Manon M Cox

BMC Biotechnol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.
Barry Buckland, Robert Boulanger, Mireli Fino, Indresh Srivastava, Kathy Holtz, Manon M J Cox

Vaccine· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis